Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:2070-2077, doi:10.1016/j.jacc.2009.02.038
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Tsukamoto, O.
Right arrow Articles by Kitakaze, M.
PubMed
Right arrow Articles by Tsukamoto, O.
Right arrow Articles by Kitakaze, M.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: HEART FAILURE

Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure

Osamu Tsukamoto, MD, PhD*,{ddagger}, Masashi Fujita, MD, PhD{ddagger}, Mahoto Kato, MD*, Satoru Yamazaki, PhD*, Yoshihiro Asano, MD, PhD{ddagger}, Akiko Ogai, PhD*, Hidetoshi Okazaki, MD, PhD*, Mitsutoshi Asai, MD{ddagger}, Yoko Nagamachi, BS{ddagger}, Norikazu Maeda, MD, PhD§, Yasunori Shintani, MD, PhD{ddagger}, Tetsuo Minamino, MD, PhD{ddagger}, Masanori Asakura, MD, PhD*, Ichiro Kishimoto, MD, PhD{dagger}, Tohru Funahashi, MD, PhD§, Hitonobu Tomoike, MD, PhD* and Masafumi Kitakaze, MD, PhD*,*

* Cardiovascular Division of Medicine, National Cardiovascular Center, Suita, Osaka, Japan
{dagger} Cardiovasular Division of Biochemistry, National Cardiovascular Center, Suita, Osaka, Japan
{ddagger} Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
§ Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Manuscript received August 27, 2008; revised manuscript received January 22, 2009, accepted February 19, 2009.

* Reprint requests and correspondence: Dr. Masafumi Kitakaze, Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka 565-8565, Japan (Email: kitakaze{at}zf6.so-net.ne.jp).

Objectives: We investigated the functional relationship between natriuretic peptides and adiponectin by performing both experimental and clinical studies.

Background: Natriuretic peptides are promising candidates for the treatment of congestive heart failure (CHF) because of their wide range of beneficial effects on the cardiovascular system. Adiponectin is a cytokine derived from adipose tissue with various cardiovascular-protective effects that has been reported to show a positive association with plasma brain natriuretic peptide (BNP) levels in patients with heart failure.

Methods: The expression of adiponectin messenger ribonucleic acid (mRNA) and its secretion were examined after atrial natriuretic peptide (ANP) or BNP was added to primary cultures of human adipocytes in the presence or absence of HS142-1 (a functional type A guanylyl cyclase receptor antagonist). Changes of the plasma adiponectin level were determined in 30 patients with CHF who were randomized to receive intravenous ANP (0.025 µg/kg/min human ANP for 3 days, n = 15) or saline (n = 15).

Results: Both ANP and BNP dose-dependently enhanced the expression of adiponectin mRNA and its secretion, whereas such enhancement was inhibited by pre-treatment with HS142-1. The plasma adiponectin level was increased at 4 days after administration of human ANP compared with the baseline value (from 6.56 ± 0.40 µg/ml to 7.34 ± 0.47 µg/ml, p < 0.05), whereas there was no change of adiponectin in the saline group (from 6.53 ± 0.57 µg/ml to 6.55 ± 0.56 µg/ml).

Conclusions: Natriuretic peptides enhance adiponectin production by human adipocytes in vitro and even in patients with CHF, which might have a beneficial effect on cardiomyocytes in patients receiving recombinant natriuretic peptide therapy for heart failure.

Key Words: adiponectin • natriuretic peptides • heart failure • adipose tissue

Abbreviations and Acronyms
  ANP = atrial natriuretic peptide
  BNP = brain natriuretic peptide
  CHF = congestive heart failure
  GC-A = type A guanylyl cyclase receptor
  hANP = human atrial natriuretic peptide
  NPR = natriuretic peptide receptor
  PKG = protein kinase G


Related Articles

A New Role for the Natriuretic Peptides: Metabolic Regulators of the Adipocyte
Lisa C. Costello-Boerrigter and John C. Burnett, Jr
J. Am. Coll. Cardiol. 2009 53: 2078-2079. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A29. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. C. Costello-Boerrigter and J. C. Burnett Jr
A new role for the natriuretic peptides metabolic regulators of the adipocyte.
J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2078 - 2079.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement